Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1984 Oct;77(10):847–854. doi: 10.1177/014107688407701010

Is there a role for radioimmunolocalization in diagnosis of intracranial malignancies?: discussion paper.

J T Kemshead, D H Jones, A Goldman, R B Richardson, H B Coakham
PMCID: PMC1440276  PMID: 6492045

Full text

PDF
847

Images in this article

849Figure 1.
on p.849
850Figure 2. A
on p.850
850Figure 2. B
on p.850
852Figure 3.
on p.852

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan P. M., Garson J. A., Harper E. I., Asser U., Coakham H. B., Brownell B., Kemshead J. T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. doi: 10.1002/ijc.2910310510. [DOI] [PubMed] [Google Scholar]
  2. Begent R. H., Searle F., Stanway G., Jewkes R. F., Jones B. E., Vernon P., Bagshawe K. D. Radioimmunolocalization of tumours by external scintigraphy after administration of 131I antibody to human chorionic gonadotrophin: preliminary communication. J R Soc Med. 1980 Sep;73(9):624–630. doi: 10.1177/014107688007300905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belitsky P., Ghose T., Aquino J., Norvell S. T., Blair A. H. Radionuclide imaging of primary renal-cell carcinoma by I-131-labeled antitumor antibody. J Nucl Med. 1978 Apr;19(4):427–430. [PubMed] [Google Scholar]
  4. Berche C., Mach J. P., Lumbroso J. D., Langlais C., Aubry F., Buchegger F., Carrel S., Rougier P., Parmentier C., Tubiana M. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) 1982 Nov 20;285(6353):1447–1451. doi: 10.1136/bmj.285.6353.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beverley P. C., Callard R. E. Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol. 1981 Apr;11(4):329–334. doi: 10.1002/eji.1830110412. [DOI] [PubMed] [Google Scholar]
  6. Bourdon M. A., Wikstrand C. J., Furthmayr H., Matthews T. J., Bigner D. D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 1983 Jun;43(6):2796–2805. [PubMed] [Google Scholar]
  7. Braun M. P., Martin P. J., Ledbetter J. A., Hansen J. A. Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood. 1983 Apr;61(4):718–725. [PubMed] [Google Scholar]
  8. Eng L. F., Vanderhaeghen J. J., Bignami A., Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971 May 7;28(2):351–354. doi: 10.1016/0006-8993(71)90668-8. [DOI] [PubMed] [Google Scholar]
  9. Epenetos A. A., Britton K. E., Mather S., Shepherd J., Granowska M., Taylor-Papadimitriou J., Nimmon C. C., Durbin H., Hawkins L. R., Malpas J. S. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet. 1982 Nov 6;2(8306):999–1005. doi: 10.1016/s0140-6736(82)90046-0. [DOI] [PubMed] [Google Scholar]
  10. Foon K. A. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Sep 9;307(11):686–687. doi: 10.1056/NEJM198209093071118. [DOI] [PubMed] [Google Scholar]
  11. Garson J. A., Beverley P. C., Coakham H. B., Harper E. I. Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species. Nature. 1982 Jul 22;298(5872):375–377. doi: 10.1038/298375a0. [DOI] [PubMed] [Google Scholar]
  12. Goldenberg D. M., DeLand F. H., Bennett S. J., Primus F. J., Nelson M. O., Flanigan R. C., McRoberts J. W., Bruce A. W., Mahan D. E. Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging. JAMA. 1983 Aug 5;250(5):630–635. doi: 10.1001/jama.250.5.630. [DOI] [PubMed] [Google Scholar]
  13. Goldenberg D. M., DeLand F., Kim E., Bennett S., Primus F. J., van Nagell J. R., Jr, Estes N., DeSimone P., Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978 Jun 22;298(25):1384–1386. doi: 10.1056/NEJM197806222982503. [DOI] [PubMed] [Google Scholar]
  14. Goldenberg D. M., Kim E. E., DeLand F. H. Human chorionic gonadotropin radioantibodies in the radioimmunodetection of cancer and for disclosure of occult metastases. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7754–7758. doi: 10.1073/pnas.78.12.7754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Johnson J. R., Ford C. H., Newman C. E., Woodhouse C. S., Rowland G. F., Simmonds R. G. A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro. Br J Cancer. 1981 Sep;44(3):472–475. doi: 10.1038/bjc.1981.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kemshead J. T., Coakham H. B. The use of monoclonal antibodies for the diagnosis of intracranial malignancies and the small round cell tumours of childhood. J Pathol. 1983 Nov;141(3):249–257. doi: 10.1002/path.1711410306. [DOI] [PubMed] [Google Scholar]
  17. Kemshead J. T., Fritschy J., Asser U., Sutherland R., Greaves M. F. Monoclonal antibodies defining markers with apparent selectivity for particular haemopoietic cell types may also detect antigens on cells of neural crest origin. Hybridoma. 1982;1(2):109–123. doi: 10.1089/hyb.1.1982.1.109. [DOI] [PubMed] [Google Scholar]
  18. Kemshead J. T., Fritschy J., Garson J. A., Allan P., Coakham H., Brown S., Asser U. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells. Int J Cancer. 1983 Feb 15;31(2):187–195. doi: 10.1002/ijc.2910310209. [DOI] [PubMed] [Google Scholar]
  19. Kemshead J. T., Goldman A., Fritschy J., Malpas J. S., Pritchard J. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet. 1983 Jan 1;1(8314-5):12–15. doi: 10.1016/s0140-6736(83)91559-3. [DOI] [PubMed] [Google Scholar]
  20. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  21. Larson S. M., Brown J. P., Wright P. W., Carrasquillo J. A., Hellström I., Hellström K. E. Imaging of melanoma with L-131-labeled monoclonal antibodies. J Nucl Med. 1983 Feb;24(2):123–129. [PubMed] [Google Scholar]
  22. Mahaley M. S., Jr Immunological considerations and the malignant glioma problem. Clin Neurosurg. 1968;15:175–189. doi: 10.1093/neurosurgery/15.cn_suppl_1.175. [DOI] [PubMed] [Google Scholar]
  23. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  24. Pallesen G., Jepsen F. L., Hastrup J., Ipsen A., Hvidberg N. Experience with the Oxford tumour marker (Ca1) in serous fluids. Lancet. 1983 Jun 11;1(8337):1326–1326. doi: 10.1016/s0140-6736(83)92430-3. [DOI] [PubMed] [Google Scholar]
  25. Phillips J., Sikora K., Watson J. V. Localisation of glioma by human monoclonal antibody. Lancet. 1982 Nov 27;2(8309):1214–1215. doi: 10.1016/s0140-6736(82)91225-9. [DOI] [PubMed] [Google Scholar]
  26. Ritz J., Sallan S. E., Bast R. C., Jr, Lipton J. M., Clavell L. A., Feeney M., Hercend T., Nathan D. G., Schlossman S. F. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet. 1982 Jul 10;2(8289):60–63. doi: 10.1016/s0140-6736(82)91686-5. [DOI] [PubMed] [Google Scholar]
  27. Schnegg J. F., Diserens A. C., Carrel S., Accolla R. S., de Tribolet N. Human glioma-associated antigens detected by monoclonal antibodies. Cancer Res. 1981 Mar;41(3):1209–1213. [PubMed] [Google Scholar]
  28. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  29. Thorpe P. E., Mason D. W., Brown A. N., Simmonds S. J., Ross W. C., Cumber A. J., Forrester J. A. Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate. Nature. 1982 Jun 17;297(5867):594–596. doi: 10.1038/297594a0. [DOI] [PubMed] [Google Scholar]
  30. Treleaven J. G., Gibson F. M., Ugelstad J., Rembaum A., Philip T., Caine G. D., Kemshead J. T. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet. 1984 Jan 14;1(8368):70–73. doi: 10.1016/s0140-6736(84)90004-7. [DOI] [PubMed] [Google Scholar]
  31. Vick N. A., Bigner D. D. Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function. J Neurol Sci. 1972 Sep;17(1):29–39. doi: 10.1016/0022-510x(72)90019-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES